Colorectal Cancer

In a recent investment column, experts discussed how physicians can apply Warren Buffett’s top financial rules to decisions they make every day. It was the top story in hematology/oncology last week.

Endoscopy in patients aged younger than 50 years decreased the incidence of colorectal cancer, according to study estimates reported at Digestive Disease Week.

Primary care practitioners need increased education and recommendations for early-onset colorectal cancer screening practices, according to a presentation at Digestive Disease Week.

Researchers found higher rates of colorectal neoplasia correlated with male sex and increased age, according to a presentation at Digestive Disease Week.

In a video exclusive, Paul Limburg, MD, Mayo Clinic, told Healio adherence rates for stool-based colorectal cancer screening and colonoscopy informed comparative effectiveness and the need for improved screening and follow-up adherence.

Screening endoscopy among otherwise healthy individuals aged older than 75 years appeared to lower the risk for colorectal cancer incidence and cancer-associated mortality, according to study results published in JAMA Oncology.

Colorectal cancer incidence and mortality decreased after implementation of a national fecal immunochemical test-based screening program in the Netherlands, according to research presented at Digestive Disease Week.

When given a choice, participants preferred fecal immunochemical test-based screening for colorectal cancer compared with a blood test, according to research presented at Digestive Disease Week.

The combination of fecal immunochemical test-based colonoscopy and fecal calprotectin detected advanced colorectal neoplasia, according to a presentation at Digestive Disease Week.

For years, standard treatment for patients with stage III colon cancer has been adjuvant chemotherapy for 6 months following resection.